Aspen Aerogels Inc (ASPN) stock
Close on Nov 17, 2026Market cap $406.65MP/E –Yield –
Earnings
Aspen Aerogels's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Aspen Aerogels's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Feb 24, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Nov 5, 2026before the open | $85.20M | +16.7% | -$0.13 | $0.11 | Release |
| Q2 FY2026ended Jun 30, 2026 | Aug 6, 2026before the open | $49.80M | -36.2% | -$0.28 | -$0.22 | Release |
| Q1 FY2026ended Mar 31, 2026 | May 7, 2026before the open | $37.90M | -51.8% | -$0.29 | -$0.28 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 25, 2026before the open | $41.30M | -66.5% | -$0.88 | -$0.34 | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 6, 2025before the open | $73.00M | -37.8% | -$0.08 | -$0.06 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 7, 2025before the open | $78.00M | -33.8% | -$0.11 | -$0.04 | Release |
| Q1 FY2025ended Mar 31, 2025 | May 8, 2025before the open | $78.70M | -16.7% | -$3.67 | -$0.06 | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 12, 2025after the close | $123.10M | +46.2% | $0.14 | – | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 6, 2024after the close | $117.30M | +92.9% | -$0.17 | – | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 7, 2024after the close | $117.80M | +144.4% | $0.21 | – | Release |
| Q1 FY2024ended Mar 31, 2024 | May 1, 2024after the close | $94.50M | +107.2% | -$0.02 | – | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 12, 2024after the close | $84.20M | +41.3% | -$0.01 | – | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 1, 2023after the close | $60.80M | +65.7% | -$0.19 | – | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 2, 2023after the close | $48.20M | +5.7% | -$0.22 | – | Release |
| Q1 FY2023ended Mar 31, 2023 | May 3, 2023after the close | $45.60M | +18.8% | -$0.24 | – | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 15, 2023after the close | $59.60M | +89.2% | -$0.20 | – | Release |
| Q3 FY2022ended Sep 30, 2022 | Oct 27, 2022after the close | $36.70M | +20.7% | -$0.75 | – | Release |
| Q2 FY2022ended Jun 30, 2022 | Jul 27, 2022after the close | $45.60M | – | -$0.68 | – | Release |
| Q1 FY2022ended Mar 31, 2022 | Apr 27, 2022after the close | $38.40M | – | -$0.59 | – | Release |
| Q4 FY2021ended Dec 31, 2021 | Feb 17, 2022after the close | $31.50M | – | -$0.50 | – | Release |
| Q3 FY2021ended Sep 30, 2021 | Oct 28, 2021after the close | $30.40M | – | -$0.24 | – | Release |
| Q2 FY2021ended Jun 30, 2021 | Jul 29, 2021after the close | – | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | Apr 29, 2021after the close | – | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Feb 18, 2021after the close | – | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Oct 29, 2020after the close | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Aspen Aerogels's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Revenue | Q4 FY2026 | $60.00M – $75.00M | – | New | Nov 5, 2026 |
| Adjusted EBITDAnon-GAAP | Q4 FY2026 | $5.00M – $13.00M | – | New | Nov 5, 2026 |
| Net loss per shareGAAP | Q4 FY2026 | -$0.13 – -$0.10 | – | New | Nov 5, 2026 |
| Net lossGAAP | Q4 FY2026 | -$11.00M – -$8.00M | – | New | Nov 5, 2026 |
| European Thermal Barrier 2026 revenue outlook | FY2026 | $20.00M – $30.00M | – | New | Aug 6, 2026 |
| Capital Expendituresnon-GAAP | FY2026 | $10.00M | – | New | Nov 5, 2026 |
| Capital Expenditures, excluding costs related to the restoration of the East Providence facility | FY2026 | $10.00M | $10.00M | Reaffirmed | Aug 6, 2026 |
Guidance vs results
The last range Aspen Aerogels gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| Q3 FY2026 | EPS (GAAP) | -$0.11 – -$0.07 | -$0.13 | Below range |
| Q3 FY2026 | Revenue | $65.00M – $80.00M | $85.20M | Above range |
| Q2 FY2026 | EPS (GAAP) | -$0.24 – -$0.17 | -$0.28 | Below range |
| Q2 FY2026 | Revenue | $40.00M – $48.00M | $49.80M | Above range |
| Q1 FY2026 | EPS (GAAP) | -$0.28 – -$0.24 | -$0.29 | Below range |
| Q1 FY2026 | Revenue | $35.00M – $40.00M | $37.90M | Within range |
| FY2025 | EPS (GAAP) | -$4.15 – -$4.05 | -$4.74Σ4Q | Below range |
| FY2025 | Revenue | $270.00M – $280.00M | $271.00MΣ4Q | Within range |
| Q2 FY2025 | EPS (GAAP) | -$0.13 – -$0.05 | -$0.11 | Within range |
| Q2 FY2025 | Revenue | $70.00M – $80.00M | $78.00M | Within range |
| Q1 FY2025 | EPS (GAAP) | -$0.18 – $0.00 | -$3.67 | Below range |
| Q1 FY2025 | Revenue | $75.00M – $95.00M | $78.70M | Within range |
Guidance history
Every forecast Aspen Aerogels put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Nov 5, 2026 | Capital Expenditures | FY2026 | $10.00M | New |
| Nov 5, 2026 | Adjusted EBITDA | Q4 FY2026 | $5.00M – $13.00M | New |
| Nov 5, 2026 | Net loss per share | Q4 FY2026 | -$0.13 – -$0.10 | New |
| Nov 5, 2026 | Net loss | Q4 FY2026 | -$11.00M – -$8.00M | New |
| Nov 5, 2026 | Revenue | Q4 FY2026 | $60.00M – $75.00M | New |
| Aug 6, 2026 | Capital Expenditures, excluding costs related to the restoration of the East Providence facility | FY2026 | $10.00M | Reaffirmed |
| Aug 6, 2026 | Adjusted EBITDA | Q3 FY2026 | $7.00M – $15.00M | New |
| Aug 6, 2026 | Net loss per share | Q3 FY2026 | -$0.11 – -$0.07 | New |
| Aug 6, 2026 | Net loss | Q3 FY2026 | -$9.00M – -$6.00M | New |
| Aug 6, 2026 | European Thermal Barrier 2026 revenue outlook | FY2026 | $20.00M – $30.00M | New |
| Aug 6, 2026 | Revenue | Q3 FY2026 | $65.00M – $80.00M | New |
| May 7, 2026 | Capital Expenditures | FY2026 | $10.00M | Reaffirmed |
| May 7, 2026 | Adjusted EBITDA | Q2 FY2026 | -$10.00M – -$4.00M | New |
| May 7, 2026 | Net loss per share | Q2 FY2026 | -$0.24 – -$0.17 | New |
| May 7, 2026 | Net loss | Q2 FY2026 | -$20.00M – -$14.00M | New |
| May 7, 2026 | revenue | Q2 FY2026 | $40.00M – $48.00M | New |
| Feb 25, 2026 | Capital Expenditures | FY2026 | $10.00M | New |
| Feb 25, 2026 | Adjusted EBITDA | Q1 FY2026 | -$13.00M – -$10.00M | New |
| Feb 25, 2026 | Net loss per share | Q1 FY2026 | -$0.28 – -$0.24 | New |
| Feb 25, 2026 | Net loss | Q1 FY2026 | -$23.00M – -$20.00M | New |
| Feb 25, 2026 | revenue | Q1 FY2026 | $35.00M – $40.00M | New |
| Nov 6, 2025 | CAPEX* | FY2025 | $25.00M | New |
| Nov 6, 2025 | Adjusted EBITDA | FY2025 | $7.00M – $15.00M | New |
| Nov 6, 2025 | Earnings Per Share (Basic) | FY2025 | -$4.15 – -$4.05 | New |
| Nov 6, 2025 | Net Income (Loss) | FY2025 | -$342.00M – -$334.00M | New |
| Nov 6, 2025 | Revenue | FY2025 | $270.00M – $280.00M | New |
| Aug 7, 2025 | CAPEX* | FY2025 | $25.00M | New |
| Aug 7, 2025 | CAPEX* | FY2025 | $10.00M | Lowered |
| Aug 7, 2025 | Adjusted EBITDA | FY2025 | $35.00M – $45.00M | New |
| Aug 7, 2025 | Adjusted EBITDA | FY2025 | $20.00M – $30.00M | Lowered |
| Aug 7, 2025 | Revenue | FY2025 | $297.00M – $317.00M | New |
| Aug 7, 2025 | Revenue | FY2025 | $140.00M – $160.00M | Lowered |
| May 8, 2025 | Capital Expenditures, excluding demobilization costs related to the Statesboro plant project | Q2 FY2025 | $10.00M | New |
| May 8, 2025 | Net loss per share | Q2 FY2025 | -$0.13 – -$0.05 | New |
| May 8, 2025 | Net loss | Q2 FY2025 | -$11.00M – -$4.00M | New |
| May 8, 2025 | Revenue | Q2 FY2025 | $70.00M – $80.00M | New |
| Feb 12, 2025 | Capital Expenditures, excluding demobilization costs related to the Statesboro plant project | Q1 FY2025 | $7.00M | New |
| Feb 12, 2025 | Net loss per share | Q1 FY2025 | -$0.18 – $0.00 | New |
| Feb 12, 2025 | revenue | Q1 FY2025 | $75.00M – $95.00M | New |
| Nov 6, 2024 | Adjusted EBITDA | FY2024 | $90.00M | Raised |
| Nov 6, 2024 | Earnings Per Share (Diluted) | FY2024 | $0.11 | Raised |
| Nov 6, 2024 | net income | FY2024 | $9.00M | Raised |
| Nov 6, 2024 | revenue | FY2024 | $450.00M | Raised |
| Aug 7, 2024 | Adjusted EBITDA | FY2024 | $60.00M | Raised |
| Aug 7, 2024 | Earnings Per Share (Diluted) | FY2024 | $0.09 | Lowered |
| Aug 7, 2024 | Net Income | FY2024 | $7.00M | Lowered |
| Aug 7, 2024 | Revenue | FY2024 | $390.00M | New |
| May 1, 2024 | Adjusted EBITDA | FY2024 | $55.00M | Raised |
| May 1, 2024 | revenue | FY2024 | $380.00M | Raised |
| Feb 12, 2024 | Capital Expenditures, excluding investments in Plant II | FY2024 | $50.00M | New |
| Feb 12, 2024 | Adjusted EBITDA | FY2024 | $30.00M | New |
| Feb 12, 2024 | Net loss per share | FY2024 | $0.30 | New |
| Feb 12, 2024 | Net loss | FY2024 | $23.00M | New |
| Feb 12, 2024 | Total revenue | FY2024 | $350.00M | New |
| Nov 1, 2023 | Capital Expenditures | FY2023 | $175.00M | Raised |
| Nov 1, 2023 | Adjusted EBITDA | FY2023 | -$40.00M – -$30.00M | Raised |
| Nov 1, 2023 | Net loss per share | FY2023 | -$0.90 – -$0.76 | Raised |
| Nov 1, 2023 | Net loss | FY2023 | -$62.40M – -$52.40M | Raised |
| Nov 1, 2023 | Total revenue | FY2023 | $225.00M | New |
| Aug 2, 2023 | CAPEX | FY2023 | $150.00M | Raised |
| Aug 2, 2023 | Adjusted EBITDA | FY2023 | -$55.00M – -$45.00M | Raised |
| Aug 2, 2023 | Net loss per share | FY2023 | -$1.21 – -$1.07 | Raised |
| Aug 2, 2023 | Net loss | FY2023 | -$85.00M – -$75.00M | Raised |
| Aug 2, 2023 | Total revenue | FY2023 | $200.00M – $250.00M | Reaffirmed |
| May 3, 2023 | CAPEX | FY2023 | $100.00M – $150.00M | New |
| May 3, 2023 | Adjusted EBITDA | FY2023 | -$60.00M – -$50.00M | Reaffirmed |
| May 3, 2023 | Net loss per share | FY2023 | -$1.46 – -$1.31 | Reaffirmed |
| May 3, 2023 | Net loss | FY2023 | -$101.90M – -$91.90M | Reaffirmed |
| May 3, 2023 | Total revenue | FY2023 | $200.00M – $250.00M | Reaffirmed |
| Feb 15, 2023 | Adjusted EBITDA | FY2023 | -$60.00M – -$50.00M | New |
| Feb 15, 2023 | Net loss per share | FY2023 | -$1.46 – -$1.31 | New |
| Feb 15, 2023 | Net loss | FY2023 | -$101.90M – -$91.90M | New |
| Feb 15, 2023 | Total revenue | FY2023 | $200.00M – $250.00M | New |
| Oct 26, 2022 | Adjusted EBITDA | FY2022 | -$62.00M – -$57.50M | Lowered |
| Oct 26, 2022 | Net loss per share | FY2022 | -$2.35 – -$2.22 | Lowered |
| Oct 26, 2022 | Net loss | FY2022 | $82.30M – $86.80M | Raised |
| Oct 26, 2022 | Total revenue | FY2022 | $180.00M | Raised |
| Jul 27, 2022 | Adjusted EBITDA | FY2022 | -$62.00M – -$55.00M | Lowered |
| Jul 27, 2022 | Net loss per share | FY2022 | -$2.35 – -$2.16 | Lowered |
| Jul 27, 2022 | Net loss | FY2022 | $79.80M – $86.80M | Raised |
| Jul 27, 2022 | Total revenue | FY2022 | $180.00M – $200.00M | New |
| Apr 27, 2022 | Adjusted EBITDA | FY2022 | -$46.00M – -$42.00M | Reaffirmed |
| Apr 27, 2022 | Net loss per share | FY2022 | $1.88 – $1.99 | Raised |
| Apr 27, 2022 | Net loss | FY2022 | $66.70M – $70.70M | Reaffirmed |
| Apr 27, 2022 | Total revenue | FY2022 | $145.00M – $155.00M | Reaffirmed |
| Feb 17, 2022 | Adjusted EBITDA | FY2022 | -$46.00M – -$42.00M | New |
| Feb 17, 2022 | Net loss per share | FY2022 | -$2.07 – -$1.95 | New |
| Feb 17, 2022 | Net loss | FY2022 | $66.70M – $70.70M | New |
| Feb 17, 2022 | Total revenue | FY2022 | $145.00M – $155.00M | New |
| Oct 28, 2021 | Adjusted EBITDA | FY2021 | -$20.50M – -$18.50M | New |
| Oct 28, 2021 | Net loss per share | FY2021 | $0.96 – $1.02 | New |
| Oct 28, 2021 | Net loss | FY2021 | $29.00M – $31.00M | New |
| Oct 28, 2021 | Total revenue | FY2021 | $122.00M – $128.00M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Aspen Aerogels filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Update
- Results
- Update
- Results
- Update
- Results
- Update
- Results
- Results
- Results
- Results
- Results
- News
See a number that looks wrong?